The Federal Trade Commission put on hold a lawsuit against pharmacy-benefit manager (PBM) units of UnitedHealth , Cigna and CVS Health over insulin prices after the Trump administration fired two of ...

FTC Chair Andrew Ferguson is no longer recusing himself from the matter, he said two days after a leadership shakeup at the agency left the case in limbo.

The FTC has paused its antitrust case against major PBMs, citing a lack of commissioners. The lawsuit alleges unfair practices that inflated insulin prices.

President Donald Trump last month fired FTC Commissioners Rebecca Kelly Slaughter and Alvaro Bedoya, the only two members participating in the action.

The FTC's general counsel had stayed the administrative complaint because the two FTC commissioners—Chair Andrew Ferguson and Melissa Holyoak—were recused from the case. Ferguson, by withdrawing his ...

The U.S. Federal Trade Commission’s lawsuit against major pharmacy benefit managers, including UnitedHealth Group’s Optum, ...

Brought forward in September, the FTC lawsuit is accusing CVS Health’s Caremark Rx, Cigna’s Express Scripts and UnitedHealth Group’s OptumRx of “engaging in anticompetitive and unfair ...

The lawsuit – which has been anticipated since the FTC published a damning report on the PBM sector in July – names CVS Health's Caremark, UnitedHealth Group's Optum, and Cigna's Express ...

FILE PHOTO: A screen displays the logo fro Cigna Corp. on the floor at the NYSE in New York ...

(Reuters) -The Federal Trade Commission put on hold a lawsuit against pharmacy-benefit manager (PBM) units of UnitedHealth, Cigna and CVS Health over insulin prices after the Trump administration ...